Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | RORB | Q92753 | 2/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL713694 | 1.00 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL29391212 | 1.00 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL713692 | 1.00 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL31493947 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL709624 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL1223741 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL2996165 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL29657093 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL29391047 | 0.89 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 | |
| SCHEMBL713693 | 0.89 | SMN1; SMN2 (0.40) | ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2537832-B1 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | CHONGQING UNISPLENDOUR CHEM CO (CN) | 2015-08-12 | — | — | EP | claimed |
| EP-1399427-A1 | PROCESS FOR THE PREPARATION OF AZOXYSTROBIN AND ANALOGUES THEREOF | Syngenta Limited (GB) | 2004-03-24 | — | — | EP | claimed |
| WO-2002100837-A1 | PROCESS FOR THE PREPARATION OF AZOXYSTROBIN AND ANALOGUES THEREOF | SYNGENTA LIMITED (GB) | 2002-12-19 | — | — | WO | claimed |
| EP-3004066-B1 | PROCESS FOR PREPARING 4,6-BIS(ARYLOXY)PYRIMIDINE DERIVATIVES | CHEMINOVA AS (DK) | 2018-04-11 | — | — | EP | disclosed |
| US-9643935-B2 | Process for preparing 4,6-BIS (aryloxy) pyrimidine derivatives | CHEMINOVA A/S (DK) | 2017-05-09 | — | — | US | disclosed |
| US-20160137612-A1 | PROCESS FOR PREPARING 4,6-BIS (ARYLOXY) PYRIMIDINE DERIVATIVES | CHEMINOVA A/S (DK) | 2016-05-19 | — | — | US | disclosed |
| EP-2537832-B1 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | CHONGQING UNISPLENDOUR CHEM CO (CN) | 2015-08-12 | — | — | EP | disclosed |
| EP-2537832-B1 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | CHONGQING UNISPLENDOUR CHEM CO (CN) | 2015-08-12 | — | — | EP | disclosed |
| EP-2076498-B1 | PREPARATION OF AZOXYSTROBIN | SYNGENTA LTD (GB) | 2015-02-25 | — | — | EP | disclosed |
| EP-2537832-A4 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | CHONGQING UNISPLENDOUR CHEM CO (CN) | 2014-08-06 | — | — | EP | disclosed |
| EP-2537832-A1 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | Chongqing Unisplendour Chemical Co., Ltd. (CN) | 2012-12-26 | — | — | EP | disclosed |
| EP-2537832-A1 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | Chongqing Unisplendour Chemical Co., Ltd. (CN) | 2012-12-26 | — | — | EP | disclosed |
| WO-2012037764-A1 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | 重庆紫光化工股份有限公司 (CN) | 2012-03-29 | — | — | WO | disclosed |
| WO-2012037764-A1 | METHOD FOR PREPARING (E)-METHYL 2-[2-(6-CHLOROPYRIMIDIN-4-YLOXY)PHENYL]-3-METHOXYACRYLATE | 重庆紫光化工股份有限公司 (CN) | 2012-03-29 | — | — | WO | disclosed |
| WO-2008093325-A2 | POLYMORPHS OF 3-(E)-2-{2-[6-(2-CYANOPHENOXY) PYRIMIDIN-4-YLOXY]PHENYL}-3-METHOXYACRYLATE | MAKHTESHIM CHEMICAL WORKS LTD. (IL) | 2008-08-07 | — | — | WO | disclosed |
| EP-1891020-A2 | PROCESSES FOR THE PREPARATION OF AZOXYSTROBIN USING DABCO AS A CATALYST AND NOVEL INTERMEDIATES USED IN THE PROCESSES | Syngenta Limited (GB) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006114572-A2 | PROCESSES FOR THE PREPARATION OF AZOXYSTROBIN USING DABCO AS A CATALYST AND NOVEL INTERMEDIATES USED IN THE PROCESSES | SYNGENTA LIMITED (GB) | 2006-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137612-A1 | PROCESS FOR PREPARING 4,6-BIS (ARYLOXY) PYRIMIDINE DERIVATIVES | NUDT1, UMPS, DPYD | ALDH1A1 1125/4885SMN1; SMN2 3435/4885MEN1 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.